Phase 3 N=30 Randomized Treatment

A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)

Supra-ventricular Tachycardia

Bottom Line

View on ClinicalTrials.gov: NCT04392362 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2021

Primary outcome: Primary: The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration — 13; 4 participants — p=0.8982

Study Design & Population

Study type: Interventional
Phase: Phase 3
Interventions: Adenosine (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Pretoria
Primary completion: Dec 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration	13; 4	0.8982

Summary

Study to compare non inferiority of giving adenosine with the simplified method vs the AHA method

Eligibility Criteria

Inclusion Criteria

Svt
normal blood pressure
normal mentation
Give consent

Exclusion Criteria

recent coffee
Allergy to adenosine
Asthma
cardiac operations

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04392362). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.